Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
22.70    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.08 (4.995%)
Market Cap: €125.81b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

Stabilisation Notice

11 Feb 2022 14:51

RNS Number : 4844B
Nomura Financial Products Europe
11 February 2022
 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

Banco Bilbao Vizcaya Argentaria S.A. (BBVA)

 

Post-stabilisation Period Announcement

 

Nomura Financial Products Europe GmbH hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Delegated Regulation (EU) 2016/1052 under the Market Abuse Regulation (EU/596/2014) and the UK FCA Stabilisation Binding Technical Standards.

 

 

Securities2

Issuer:

Banco Bilbao Vizcaya Argentaria S.A. (BBVA)

Guarantor(s) (if any):

NA

Aggregate nominal amount:

EUR 1bn

Description:

EUR 1bn Banco Bilbao Vizcaya Argentaria S.A (BBVA) due on 14th January 2022. Coupon: 0.875% Maturity: 14th Jan 2029 ISIN: XS2430998893

Offer price:

TBD

Other offer terms:

NA

 

Stabilisation:

Stabilisation Manager(s):4

BBVA, IMI Sigeco SIM, Natixis, Natwest Markets, Nomura, Societe Generale

 

Stabilisation period expected to start on:5

05th Jan 2022

Stabilisation period expected to end no later than:6

13th Feb 2022

Existence, maximum size and conditions of use of overallotment facility:8

The Stabilisation Manager(s) may overallot the securities to the extent permitted in accordance with applicable law.

Stabilisation trading venue(s):9

TBD

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may overallot10 the securities or effect transactions with a view to supporting the market price of the securities during the stabilisation period at a level higher than that which might otherwise prevail. However, stabilisation may not necessarily occur and any stabilisation action, if begun, may cease at any time. Any stabilisation action or overallotment shall be conducted in accordance with all applicable laws and rules.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within Article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom12.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with Regulation (EU) 2017/1129 (the "(EEA Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority that Member State in accordance with the EEA Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the EEA Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STATBMITMTIBBLT
Date   Source Headline
29th Apr 20257:14 amRNSResults Press Release
29th Apr 20257:10 amRNS1Q25 Earnings Presentation
24th Apr 20257:00 amRNSRedemption of Public Sector Covered Bonds
24th Apr 20257:00 amRNSRedemption of Mortgage Covered Bonds
22nd Apr 202510:45 amRNS1Q 2025 earnings announcement
1st Apr 20255:26 pmRNSEarly redemption of Senior Preferred Notes
1st Apr 20255:19 pmRNSEarly redemption of Senior Preferred Notes
28th Mar 20257:25 amRNSAdjunstments on the tender offer to Banco Sabadell
21st Mar 20255:18 pmRNSPrudential Relevance Report - Pillar 3 2024
21st Mar 20254:39 pmRNSResult of AGM
11th Mar 20259:27 amRNSStabilisation Notice - BBVA
17th Feb 20253:27 pmRNSStabilisation Notice-BBVA
17th Feb 20257:56 amRNSStabilisation Notice- BBVA
14th Feb 20255:39 pmRNS2025 AGM Notice and Proposed Resolutions
14th Feb 20255:38 pmRNSApril dividend calendar
12th Feb 20257:00 amRNS2025 Annual General Meeting Call
30th Jan 20257:00 amRNSShareholder remuneration for 2024
30th Jan 20257:00 amRNS4Q24 Results Press Release
30th Jan 20257:00 amRNS4Q24 Earnings Presentation
30th Jan 20257:00 amRNS4Q24 Quarterly Report
28th Jan 20255:07 pmRNSRedemption of preferred securities
22nd Jan 202510:32 amRNSBBVA 4Q24 Quarterly Results
9th Jan 20255:48 pmRNSBBVA offer modification
8th Jan 20257:00 amRNSIssue of preferred securities
27th Dec 20247:00 amRNSForm-8.3 Smith (DS) plc - BBVA SA - Unwind 1
23rd Dec 20245:11 pmRNSForm-8.3 Smith (DS) plc - BBVA SA
11th Dec 20245:44 pmRNSBBVA Minimum Capital Requirements for 2025
4th Dec 20245:04 pmRNSEarly Redemption of Subordinated Notes issuance
12th Nov 20245:48 pmRNSCNMC's Resolution on Commencement of Second Phase
31st Oct 20247:00 amRNS3Q24 Results Report
31st Oct 20247:00 amRNS3Q24 Results Press Release
31st Oct 20247:00 amRNS3Q24 Results Presentation
23rd Oct 202411:15 amRNS3Q24 Earnings Presentation Announcement
1st Oct 20246:29 pmRNSAdjustments to the Offer consideration
26th Sep 20248:51 amRNSPost Stabilisation Notice - BBVA 12NC7 Tier 2
26th Sep 20247:04 amRNSIssue of securities contingently convertible
26th Sep 20247:00 amRNSDividend October 2024
5th Sep 20245:17 pmRNSECB Non-opposition to tender offer for B. Sabadell
3rd Sep 20247:26 amRNSAuthorization from the Prudential Regula Authority
31st Jul 20247:00 amRNS2Q24 Results Press Release
31st Jul 20247:00 amRNS2Q24 Results Presentation
31st Jul 20247:00 amRNS2Q24 Results Report
30th Jul 20245:34 pmRNSOrganizational changes
24th Jul 202410:25 amRNS2Q24 Results Presentation Announcement
5th Jul 202411:31 amRNSResolutions adopted at the 2024 Extraordinary AGM
4th Jun 20246:01 pmRNSIssue of preferred securities contingently conv
31st May 20247:00 amRNSBBVA’s Extraordinary General Meeting Call
24th May 20245:52 pmRNSRequest for authorisation voluntary takeover bid
24th May 20245:10 pmRNSBBVAs share capital reduction
9th May 20249:36 amRNSOffer to Banco Sabadell Shareholders Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.